Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

Lunger, Fabian; Peros, Georgios (2020). Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer. memo - Magazine of European Medical Oncology, 13(3), pp. 324-328. Springer 10.1007/s12254-020-00586-0

Text Lunger-Peros2020_Article_ChemoradiotherapyAloneOrChemor.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (274kB) | Request a copy

In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision. However, in 10–40% of all patients, a complete clinical remission can be detected after completion of chemoradiotherapy. Recent studies have shown that those patients omitting radical surgery after successful neoadjuvant pretreatment can be safely managed within a close follow-up network without compromising short-term overall and disease-free survival. However, available data suggest that 20–30% of all patients assigned to a watch and wait regimen will eventually have to be transferred to surgical management due to local recurrence. Careful patient selection is key for a successful watch and wait approach and the choice of non-operative management should not be made after completion of staging but rather after neoadjuvant chemoradiotherapy. Selected patients need to be thoroughly informed that there is still no standardized follow-up protocol and no predefined follow-up period.

Interest & Impact

Downloads

1 since deposited on 07 Jan 2021
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item